I certainly trust your information but I do not yet see that any actual shares were sold/placed - int he filing it says they can sell the shares from time to time at an "at the market" price.
Jefferies is the sole Agent. On December 12, Jefferies raised their stock price target from $8 to $9. Funny how it all works.
And then the company is happy to announce this:
CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (IBRX.NaE) , a commercial-stage immunotherapy company, today announced that OncoDaily has recognized Dr. Patrick Soon-Shiong as being one of “The 100 Most Influential People in Oncology in 2025.” Soon-Shiong is the company’s Founder, Executive Chairman and Global Chief Scientific and Medical Officer, and is a global thought leader in advancing the goal of a cancer-free society.
On its website announcing the honor, OncoDaily highlighted Soon-Shiong’s extensive scientific and research accomplishments, noting that The 100 Most Influential People in Oncology in 2025 recognizes changemakers in cancer care who have helped shape current oncology practice and continue to drive innovation across research, patient outcomes, advocacy, philanthropy, leadership, and education.
OncoDaily, the “Voice of Oncology,” is a respected global source of news and information about developments in oncology, whose editorial staff and advisory board is comprised of leading academics, researchers and physicians specializing in cancer. Its annual Influential People list highlights individuals whose work is shaping oncology through clinical leadership, scientific innovation, education, advocacy, and philanthropy.
“Dr. Soon-Shiong has earned this honor in recognition of his lifelong commitment to science, medicine, and patient care, a commitment that inspires our team and our partners every day,” said Richard Adcock, President and CEO of ImmunityBio (IBRX.NaE). “His ideas and leadership are a driving force powering our mission to bring transformative therapies to people living with cancer and other serious diseases.” |
